Biosafe

Stem cell processing technology for Regenerative Medicine and Stem Cell Banking applications

Biosafe, present in 40 countries, is world leader in automated adult stem cell processing for stem cell banking and regenerative medicine applications.
Sepax, Biosafe’s lead technology platform, is a versatile cell separation technology based on a unique proprietary separation chamber that allows the processing of cellular product volumes from 35ml to 880ml.
The combination of the compact Sepax main processing unit and a single-use kit consumable provides a fully automated, GMP, closed environment suitable for use in a stem cell laboratory or bedside – no additional equipment is required.
Biosafe products are used in hundreds of procedures every day and significant transplant outcome data is a clear indication of product efficacy, safety and quality.
An active participant in its fields of interest Biosafe is notably a proud Official Collaborator of the Netcord organisation that groups leading cord blood banks around the world.
Biosafe SA is a US FDA registered establishment, Japan MHLW approved as well as an ISO 9001:2000 and ISO 13485:2003 certified company, working under the European Medical Devices Directive 93/42/EEC annex II.3.

Claude Fell – CEO, President
Christopher Bolton – CFO
Toby Hamblin – Director Sales & Marketing

Route du Petit-Eysins
Eysins
CH-1262 Switzerland